Structural basis of CpG and inhibitory DNA recognition by Toll-like receptor 9
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Innate immunity serves as the first line of defence against invading pathogens such as bacteria and viruses. Toll-like receptors (TLRs) are examples of innate immune receptors, which sense specific molecular patterns from pathogens and activate immune responses. TLR9 recognizes bacterial and viral DNA containing the cytosine-phosphate-guanine (CpG) dideoxynucleotide motif. The molecular basis by which CpG-containing DNA (CpG-DNA) elicits immunostimulatory activity via TLR9 remains to be elucidated. Here we show the crystal structures of three forms of TLR9: unliganded, bound to agonistic CpG-DNA, and bound to inhibitory DNA (iDNA). Agonistic-CpG-DNA-bound TLR9 formed a symmetric TLR9-CpG-DNA complex with 2:2 stoichiometry, whereas iDNA-bound TLR9 was a monomer. CpG-DNA was recognized by both protomers in the dimer, in particular by the amino-terminal fragment (LRRNT-LRR10) from one protomer and the carboxy-terminal fragment (LRR20-LRR22) from the other. The iDNA, which formed a stem-loop structure suitable for binding by intramolecular base pairing, bound to the concave surface from LRR2-LRR10. This structure serves as an important basis for improving our understanding of the functional mechanisms of TLR9.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Structural studies recently described two different TLR9i sequences that formed stem-loop structures that fit snugly into the interior of the ring structure of TLR9, preventing dimerization and activation (21).”
From Engineering adeno-associated viral vectors to evade innate immune and inflammatory responses (2021) · cites this paper as [21]
In the citing paper
“the binding site of TLR9i oligonucleotides on TLR9 partially overlapped with that of CpG DNA, and the TLR9i oligonucleotide tested possessed higher binding affinity for TLR9 than CpG DNA”
From Engineering adeno-associated viral vectors to evade innate immune and inflammatory responses (2021) · cites this paper as [21]
Citations
Cites
[20] Processing of X-ray diffraction data collected in oscillation mode
Otwinowski, Z., & Minor, W. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)76066-x · Cited by 33,475
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
The PyMOL Molecular Graphics System
DeLano, W. L. (2002) · Medical Entomology and Zoology · Cited by 18,147
Refinement of Macromolecular Structures by the Maximum-Likelihood Method
Murshudov, G. N., Vagin, A. A., & Dodson, E. J. (1997) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444996012255 · Cited by 14,742
MolProbity : all-atom structure validation for macromolecular crystallography
Chen, V. B., Arendall, W. B., Headd, J. J., Keedy, D. A., Immormino, R. M., Kapral, G. J., Murray, L. W., Richardson, J. S., & Richardson, D. C. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909042073 · Cited by 14,115
Janeway, C. A., & Medzhitov, R. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.083001.084359 · Cited by 8,394
Akira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312
A Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491
PHENIX : building new software for automated crystallographic structure determination
Adams, P. D., Grosse-Kunstleve, R. W., Hung, L.-W., Ioerger, T. R., McCoy, A. J., Moriarty, N. W., Read, R. J., Sacchettini, J. C., Sauter, N. K., & Terwilliger, T. C. (2002) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444902016657 · Cited by 4,361
Schuck, P. (2000) · Biophysical Journal · doi:10.1016/s0006-3495(00)76713-0 · Cited by 3,868
Cited by
Items 201–300 of 381
Duan, D., & Herzog, R. W. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2025.12.067 · Cited by 25
Horie, A., Tomita, Y., Ohshio, K., Fujiwara, D., & Fujii, T. (2019) · BMC Microbiology · doi:10.1186/s12866-019-1458-y · Cited by 14
Werner, W., Kuzminskaya, M., Lurje, I., Tacke, F., & Hammerich, L. (2024) · Seminars in Liver Disease · doi:10.1055/a-2334-8311 · Cited by 15
TLR9 stability and signaling are regulated by phosphorylation and cell stress
Hasan, M., Gruber, E. J., Cameron, J. L., & Leifer, C. A. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.2a0815-337r · Cited by 13
Enhanced Immunostimulatory Activity of Covalent DNA Dendrons
Kawamoto, Y., Liu, W., Yum, J. H., Park, S., Sugiyama, H., Takahashi, Y., & Takakura, Y. (2021) · ChemBioChem · doi:10.1002/cbic.202100583 · Cited by 13
Toll-like receptors: New targets for multiple myeloma treatment?
Atutxa, O. A., Buey, B., Beltrán‐Visiedo, M., Giraldos, D., Marzo, I., & Latorre, E. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.114992 · Cited by 16
The Evolution of the Toll-Like Receptor System
Voogdt, C. G. P., & van Putten, J. P. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801975-7.00013-x · Cited by 18
Sensing Self and Non-Self DNA by Innate Immune Receptors and Their Signaling Pathways
Sok, S. P. M., Ori, D., Nagoor, N. H., & Kawai, T. (2018) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2018026540 · Cited by 14
Synthesis and properties of GuNA purine/pyrimidine nucleosides and oligonucleotides
Kumagai, S., Sawamoto, H., Takegawa-Araki, T., Arai, Y., Yamakoshi, S., Yamada, K., Ohta, T., Kawanishi, E., Horie, N., Yamaguchi, T., et al. (2020) · Organic & Biomolecular Chemistry · doi:10.1039/d0ob01970d · Cited by 13
DNA origami: Interrogating the nano-landscape of immune receptor activation
Hou, Y., & Treanor, B. (2023) · Biophysical Journal · doi:10.1016/j.bpj.2023.10.013 · Cited by 13
Nucleic Acid Sensor-Mediated PANoptosis in Viral Infection
Zhu, L., Qi, Z., Zhang, H., & Wang, N. (2024) · Viruses · doi:10.3390/v16060966 · Cited by 16
“Structural studies reveal that TLR9 forms a symmetric complex with CpG-DNA via its extracellular domain [31].”
BackgroundApplications of nanotechnology in remodeling the tumour microenvironment for glioblastoma treatment
Mu, Y., Zhang, Z., Zhou, H., Ma, L., & Wang, D. (2024) · Biomaterials Science · doi:10.1039/d4bm00665h · Cited by 13
Dynamic control of nucleic-acid-sensing Toll-like receptors by the endosomal compartment
Miyake, K., Saitoh, S.-I., Fukui, R., Shibata, T., Sato, R., & Murakami, Y. (2021) · International Immunology · doi:10.1093/intimm/dxab037 · Cited by 14
Self-citationBatkhishig, D., Bilguun, K., Enkhbayar, P., Miyashita, H., Kretsinger, R. H., & Matsushima, N. (2018) · The Protein Journal · doi:10.1007/s10930-018-9767-9 · Cited by 12
Precision Medicine-Enabled Cancer Immunotherapy
Lee, J. K., & Priceman, S. J. (2019) · Cancer treatment and research · doi:10.1007/978-3-030-16391-4_7 · Cited by 13
Overcoming Immune Therapy Resistance in Cancer Through Innate Immune Reprogramming
Mandracci, G., Soliman, N., & Khawanky, N. E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199554 · Cited by 15
“Global DNA hypomethylation, a hallmark of tumorigenesis, arises from dysregulation of DNA methyltransferases (DNMTs), aberrant activity of ten-eleven translocation (TET) family demethylases, and replication-associated loss of methylation fidelity in rapidly dividing cells [50].”
Zhang, L., Zhang, L., Wang, Y., Jiang, K., Gao, C., Zhang, P., Xie, Y., Wang, B., Zhao, Y., Xiao, H., et al. (2023) · Nanoscale Advances · doi:10.1039/d3na00322a · Cited by 10
Kim, J., Yuan, Y., Agaronyan, K., Zhao, A., Wang, V., Gau, D. M., Toosi, N., Gupta, G., Essayas, H., Kaminski, A., et al. (2025) · Mucosal Immunology · doi:10.1016/j.mucimm.2025.01.008 · Cited by 15
Cytidine deaminase enables Toll-like receptor 8 activation by cytidine or its analogs
Furusho, K., Shibata, T., Sato, R., Fukui, R., Motoi, Y., Zhang, Y., Saitoh, S.-I., Ichinohe, T., Moriyama, M., Nakamura, S., et al. (2018) · International Immunology · doi:10.1093/intimm/dxy075 · Cited by 11
Self-citationOligonucleotide–Polymer Conjugates: From Molecular Basics to Practical Application
Xiao, F., Wei, Z., Wang, M., Hoff, A., Bao, Y., & Tian, L. (2020) · Topics in Current Chemistry · doi:10.1007/s41061-020-0286-8 · Cited by 12
“a A CpG oligodeoxynucletide (ODN) containing a “C–G” sequence can elicit an immune response in a mammal through the TLR9 signaling pathway, thereby enhancing immunotherapy as an immunological adjuvant [7].”
BackgroundLiu, K. Y., Sengillo, J. D., Velez, G., Jauregui, R., Sakai, L. Y., Maumenee, I. H., Bassuk, A. G., Mahajan, V. B., & Tsang, S. H. (2018) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-018-0885-4 · Cited by 10
“The leucine-rich repeat domains (LRR1–4; residues 30– 909) were modelled off the mouse Toll-like receptor-9 structure (PDB: 3WPF; 24% sequence identity) [20].”
MethodCharacterization of cooperative PS-oligo activation of human TLR9
Pollak, A. J., Zhao, L., & Crooke, S. T. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.08.011 · Cited by 10
Ushach, I., Zhu, R., Rosler, E. S., Pandey, R. K., Costa, N. T. S. D., Pourshahian, S., Han, Q., Li, C., Beigelman, L. N., Gryaznov, S. M., et al. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.01.020 · Cited by 10
Selective Integrin α5β1 Targeting through Spatially Constrained Multivalent DNA-Based Nanoparticles
Kurisinkal, E. E., Caroprese, V., Koga, M. M., Morzy, D., & Bastings, M. M. C. (2022) · Molecules · doi:10.3390/molecules27154968 · Cited by 11
Virome and Inflammasomes, a Finely Tuned Balance with Important Consequences for the Host Health
Freer, G., Maggi, F., & Pistello, M. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867324666171005112921 · Cited by 11
Cheng, D., Wu, X., Jia, R., Wang, M., Chen, S., Liu, M., Zhu, D., Zhao, X., Wu, Y., Yang, Q., et al. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.12.019 · Cited by 11
Harnessing biomaterial architecture to drive anticancer innate immunity
Davis, M. A., Cho, E., & Teplensky, M. H. (2023) · Journal of Materials Chemistry B · doi:10.1039/d3tb01677c · Cited by 9
Kang, M. H., Thomas, S. P., Westley, C., Blouin, T., Xu, L., Chan, Y., Lisk, E., Allen, S., Vadivel, A., Nangle, K., et al. (2025) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2024-0247oc · Cited by 9
Araie, Y., Ohtsuki, S., Park, S., Nagaoka, M., Umemura, K., Sugiyama, H., Kusamori, K., Takahashi, Y., Takakura, Y., & Nishikawa, M. (2020) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2020.115864 · Cited by 9
The evolutionary characteristics and structural biology of Gallus toll‐like receptor 21
Wu, H., Wang, H., Jiang, W., & Lian, Z. (2017) · Journal of Molecular Recognition · doi:10.1002/jmr.2696 · Cited by 9
Peng, J., Xiao, Y., Wan, X., Chen, Q., Wang, H., Li, J., Chen, J., & Gao, R. (2020) · Vaccines · doi:10.3390/vaccines8030552 · Cited by 11
Bioinformatics analysis of the structural and evolutionary characteristics for toll-like receptor 15
Wang, J., Zhang, Z., Chang, F., & Yin, D. (2016) · PeerJ · doi:10.7717/peerj.2079 · Cited by 11
“TLR2 is able to form a 47 heterodimer with TLR1, TLR6 or TLR10 to detect microbial lipopeptides (Guan et al. 2010; Jin 48 et al. 2007; Kang et al. 2009); TLR3 and TLR22 detect double-stranded RNA (Liu et al. 2008; 49 Matsuo et al. 2008); TLR4 recognizes to lipopolysaccharides from Gram-negative bacteria (Park 50 et al…”
BackgroundInfluentialWei, Y., Li, W., Xu, R., Xu, C., Li, X., Li, N., Xu, F., Yang, K., & Yuan, B. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102011 · Cited by 9
“These results collectively demonstrate the critical role of lysosomal localization and TLR9 engagement in mediating the immune-stimulatory effects of both CpG and L/C NPs, aligning with previous reports on peptide-nucleic acid complexes [4,42,43].”
Innate immune sensors for detecting nucleic acids during infection
Ghoreshi, Z., Nakhaee, M., Samie, M., Zak, M. S., & Arefinia, N. (2022) · Journal of Laboratory Medicine · doi:10.1515/labmed-2021-0173 · Cited by 10
“During viral infections, IFI16 binds to the same location of pathogenic ds DNAs via PYRIN domain (PYD)-PYD interaction to form filaments [80] NLS acetylation in IFI16 by P300 acetyltransferase promotes IFI16 cytoplasmic export [43].”
BackgroundInfluentialCrosstalk between myocardial autophagy and sterile inflammation in the development of heart failure
Tang, J., Tam, E., Song, E., Xu, A., & Sweeney, G. (2024) · Autophagy Reports · doi:10.1080/27694127.2024.2320605 · Cited by 10
Tsukamoto, Y., Tamura, T., Maeda, Y., Miyake, K., & Ato, M. (2019) · Tuberculosis · doi:10.1016/j.tube.2019.101890 · Cited by 8
Self-citationSioud, M. (2023) · Scandinavian Journal of Immunology · doi:10.1111/sji.13282 · Cited by 10
TLR9 Monotherapy in Immune-Competent Mice Suppresses Orthotopic Prostate Tumor Development
Miles, M. A., Luong, R., To, E. E., Erlich, J. R., Liong, S., Liong, F., Logan, J. M., O’Leary, J. J., Brooks, D. A., & Selemidis, S. (2024) · Cells · doi:10.3390/cells13010097 · Cited by 8
“In this study, we investigated the role of TLR9, which is responsible for the detection of unmethylated cytosine–guanine dinucleotide (CPG) sequences in DNA from bacteria and viruses [17,18] within the endosomal compartment.”
BackgroundLi, C., Li, Y., Zhou, B., Li, T., Wei, X., Chen, K., Chen, W., Shi, Z., Dai, X., Zhang, J., et al. (2025) · Nature Biomedical Engineering · doi:10.1038/s41551-025-01431-7 · Cited by 11
“8i), consistent with the studies in the literature 83,84 .”
Catch me if you can: viral nucleic acids to host sensors
Jung, Y., Grainger, H., Yang, S., Mondal, S., Lukong, K. E., Conn, K. L., & Wu, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1632283 · Cited by 8
“TLR9 binds two types of DNA: one site recognizes CpG DNA, while another recognizes 5 ′ -xCx DNA (cytosine at the second position from the 5 ′ end) (53, 54).”
Amato, M., Lupi, S. M., Polizzi, A., Santonocito, S., Viglianisi, G., Cicciù, M., & Isola, G. (2023) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2410287 · Cited by 10
“CpG DNA is a kind of DNA sequence which can activate the immune response through TLR9; this receptor is expressed at elevated concentrations in periodontitis-affected gingival tissue, indicating the involvement of CpG DNA in periodontal disease [ 89–91].”
BackgroundDNA tetrahedron nanoparticles service as a help carrier and adjvant of mRNA vaccine
Liu, H., Li, X., Yan, R., Yang, J., Lü, Q., & Wang, L. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05837-w · Cited by 8
“These motifs are recognized by toll-like receptors (TLRs) 9, initiating intracellular signal cascades that upregulate pro-inflammatory cytokines, chemokines, and co-stimulatory molecules [33].”
Khurshid, S., Venkataramany, A. S., Montes, M., Kipp, J. F., Roberts, R. D., Wein, N., Rigo, F., Wang, P.-Y., Cripe, T. P., & Chandler, D. S. (2024) · Molecular Therapy Oncology · doi:10.1016/j.omton.2024.200908 · Cited by 7
Single-stranded oligodeoxynucleotides induce plant defence in Arabidopsis thaliana
Toum, L., Conti, G., Guerriero, F. C., Conforte, V. P., Garolla, F. A., Asurmendi, S., Vojnov, A. A., & Gudesblat, G. E. (2020) · Annals of Botany · doi:10.1093/aob/mcaa061 · Cited by 10
Arega, A. M., Pattanaik, K. P., Nayak, S., & Mahapatra, R. K. (2021) · Acta Tropica · doi:10.1016/j.actatropica.2021.105870 · Cited by 7
Immunological effects of different types of synthetic CpG oligodeoxynucleotides on porcine cells
Li, R., Zhang, L., Shi, P., Deng, H., Li, Y. L., Ren, J., Fu, X., Zhang, L., & Huang, J. (2017) · RSC Advances · doi:10.1039/c7ra04493c · Cited by 7
Long, Y., Zhao, X. T., Xia, C.-S., Liu, X., Fan, C., & Liu, C. (2020) · Immunological Investigations · doi:10.1080/08820139.2020.1723021 · Cited by 8
How studies on inflamm-aging may help to understand and combat COVID-19 pandemic.Preprint
Storci, G., Bonifazi, F., Garagnani, P., Olivieri, F., & Bonafè, M. (2020) · Preprints.org · doi:10.20944/preprints202004.0158.v1 · Cited by 7
Rational Design of DNA Nanostructures as TLR9 Agonists
Chen, C., Tian, C., Jin, Z., Wen, Y., Xia, X., Ren, Q., Huang, C. Z., & Zuo, H. (2025) · Biomacromolecules · doi:10.1021/acs.biomac.5c00919 · Cited by 6
Styczeń, A., Krysa, M., Mertowska, P., Grywalska, E., Urbanowicz, T. K., Krasiński, M., Grobelna, M., Topyła, W., Rahnama, M., & Tomaszewski, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262211143 · Cited by 7
“The mechanism of action of the described transmembrane glycoprotein consists of detecting molecules associated with damage to the body’s own tissues (DAMPs), which come from inside the cell [144,145].”
Zhang, S., Li, B., Liu, L., Gong, D., Zhang, D., Liu, F., Yang, X., Qin, H., Kong, D., Zhang, S., et al. (2025) · Cell Research · doi:10.1038/s41422-025-01178-5 · Cited by 7
Equilibrium Binding Model for CpG DNA-Dependent Dimerization of Toll-like Receptor 9 Ectodomain
Reikine, S., McLaughlin, S. H., Johnson, C. M., & Modis, Y. (2020) · Biochemistry · doi:10.1021/acs.biochem.0c00466 · Cited by 6
Qu, Y., Rose, R. D., Kim, C., Zhou, J., Lin, Z., Ju, Y., Bhangu, S. K., Cortez‐Jugo, C., Cavalieri, F., & Caruso, F. (2023) · Angewandte Chemie · doi:10.1002/ange.202214935 · Cited by 6
Jang, H.-E., Jung, H., & Mok, H. (2017) · Applied Biological Chemistry · doi:10.1007/s13765-017-0284-x · Cited by 7
Dondapati, S. K., Pietruschka, G., Thoring, L., Wüstenhagen, D. A., & Kubick, S. (2019) · PLoS ONE · doi:10.1371/journal.pone.0215897 · Cited by 10
The effect of anesthetics on toll like receptor 9
Koutsogiannaki, S., Bu, W., Hou, L., Shibamura‐Fujiogi, M., Ishida, H., Ohto, U., Eckenhoff, R. G., & Yuki, K. (2020) · The FASEB Journal · doi:10.1096/fj.202000791rr · Cited by 6
Self-citationRoki, N., Solomon, M. A., Bowers, J., Getts, L. A., Getts, R. C., & Muro, S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14071496 · Cited by 6
“3DNA has been designed to avoid CpG sequences and minimize recognition by Toll-like receptors and activation of immune cascades [49], which could be further avoided by using non-natural nucleic acids [50].”
BackgroundMatsushima, N., Miyashita, H., Batkhishig, D., & Kretsinger, R. H. (2023) · Journal of Cellular Signaling · doi:10.33696/signaling.4.098 · Cited by 4
“The structure of the TLR9-CpG DNA complex reveals that CpG-DNA is recognized by both promoters, in particular by the N-terminal LRRNT– LRR10 fragment from one protomer and the C-terminalterminal fragment (LRR20–LRR22) from the other [142,143].”
BackgroundAndini, T. M., Tada, S., Kumagai, T., Takahashi, Y., Higuchi, Y., Kawamoto, Y., & Park, S. (2025) · Organic & Biomolecular Chemistry · doi:10.1039/d4ob02034k · Cited by 5
Hartmann, G. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.102078 · Cited by 5
“8,9 In this context, it is important to keep in mind that in those studies, (1) most structural information is derived from TLR9 of species other than human, (2) structural studies were performed with un-modi fi ed phosphodiester oligonucleotides, while phosphorothioate oligonucleotides were used in…”
BackgroundTuning CpG motif position in nanostructured DNA for efficient immune stimulation
Tan, M., Makiguchi, N., Kusamori, K., Itakura, S., Takahashi, Y., Takakura, Y., & Nishikawa, M. (2024) · Biotechnology Journal · doi:10.1002/biot.202300308 · Cited by 5
Pattern Recognition Receptors in Autoinflammation
Saavedra, V., Moghaddas, F., Latz, E., & Masters, S. L. (2019) · Springer eBooks · doi:10.1007/978-3-319-98605-0_4 · Cited by 7
Ezzemani, W., Ouladlahsen, A., Altawalah, H., Saı̈le, R., Sarih, M., Kettani, A., & Ezzikouri, S. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2226733 · Cited by 5
“It also plays a possible functional role in the molecular mechanism by which TLR9 specifically recognizes CpG-DNA and signals to the intracellular compartment (Ohto et al., 2015).”
BackgroundMethodCancer Immunotherapy—An Emerging Field That Bridges Oncology and Immunology Research
Adams, J. L., Duffy, K. J., Moore, M. L., & Yang, J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12400-x · Cited by 9
G-quadruplex-forming oligodeoxyribonucleotides activate leukotriene synthesis in human neutrophils
Viryasova, G. M., Dolinnaya, N. G., Golenkina, E. A., Gaponova, T. V., Viryasov, M. B., Romanova, Y. M., & Sud’ina, G. F. (2018) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2018.1523748 · Cited by 5
Liao, W., Akahira, S., Kuwahara, H., Wada, T., Kusamori, K., Takakura, Y., & Nishikawa, M. (2020) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b20-00052 · Cited by 5
Lin, F., Tang, Y., & Zheng, C. (2021) · International Reviews of Immunology · doi:10.1080/08830185.2021.1898605 · Cited by 5
N-glycosylation of UNC93B1 at a Specific Asparagine Residue Is Required for TLR9 Signaling
Song, H.-S., Park, S., Huh, J., Lee, Y., Jung, D.-J., Yang, C., Ys, K., Kim, H. M., & Kim, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.875083 · Cited by 9
Golenkina, E. A., Galkina, S. I., Viryasova, G. M., & Sud’ina, G. F. (2023) · Oxygen · doi:10.3390/oxygen3010002 · Cited by 5
(N7)-Platination and its effect on (N1)H-acidification in nucleoside phosphate derivatives
Sigel, A., Operschall, B. P., Griesser, R., Song, B., Okruszek, A., Odani, A., Katsuta, T., Lippert, B., & Sigel, H. (2016) · Inorganica Chimica Acta · doi:10.1016/j.ica.2016.02.048 · Cited by 6
Sanjaya, A., Elder, J. R., & Shah, D. H. (2017) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2017.08.005 · Cited by 6
Whitehead, L., & Brown, G. D. (2017) · Wiley-VCH eBooks · doi:10.1002/9783527692156.ch8 · Cited by 7
Cross-kingdom microbial interactions in the gut during inflammatory bowel disease
Li, L., Cai, F., Liu, Z., Mo, W., Zhang, J., Qin, J., Liang, C., Xu, H., Liu, S., Tang, S., et al. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-07692-3 · Cited by 5
Jeong, U., Lee, W., Choi, Y. S., Haseeb, M., Baek, W., Han, J. H., Choi, H., Kim, M. S., Suh, C., Kim, W., et al. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01526-w · Cited by 5
“A human TLR9 model was constructed through homology modeling using 3WPC as a template on the SWISS-MODEL web server 28,29 .”
Boulch, M. L., Jacquet, E., Nhiri, N., Shmulevitz, M., & Jais, P. H. (2024) · Scientific Reports · doi:10.1038/s41598-024-55947-0 · Cited by 4
“…or inducibly, or on the use of cell lines modified by editing certain genes involved in the innate cellular immune response to exogenous DNA such as the Toll-like membrane receptor 9 for unmethylated CpG DNA 49 , or cyclic GMP-AMP synthase (cGAS)-STING pathway that senses DNA in the cytoplasm 50 .”
BackgroundSequence and functional variability of Toll-like receptor 9 gene in equines
Manuja, A., Manuja, B. K., & Singha, H. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.10.010 · Cited by 4
TLR9 Polymorphisms Might Contribute to the Ethnicity Bias for EBV-Infected Nasopharyngeal Carcinoma
Chattopadhyay, N. R., Chatterjee, K., Tiwari, N., Chakrabarti, S., Sahu, S. K., Roy, S. D., Ghosh, A., Reddy, R. R., Das, P., Mal, S., et al. (2020) · iScience · doi:10.1016/j.isci.2020.100937 · Cited by 4
Viryasova, G. M., Golenkina, E. A., Hianik, T., Soshnikova, N. V., Dolinnaya, N. G., Gaponova, T. V., Romanova, Y. M., & Sud’ina, G. F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052671 · Cited by 5
Barbosa, L. M., Santiago, M. B., Moretto, V. T., Athanazio, D. A., Takahashi, D., Reis, E. G., Lopes, M., Lemaire, D. C., & dos Reis, M. G. (2021) · Brazilian Journal of Biology · doi:10.1590/1519-6984.244123 · Cited by 4
Structural analysis of the Toll-like receptor 15 TIR domain
Ko, K. Y., Song, W. S., Park, J., Lee, G., & Yoon, S. (2023) · IUCrJ · doi:10.1107/s2052252523002956 · Cited by 4
Golenkina, E. A., Viryasova, G. M., Dolinnaya, N. G., Bannikova, V. A., Gaponova, T. V., Romanova, Y. M., & Sud’ina, G. F. (2020) · Biomolecules · doi:10.3390/biom10020249 · Cited by 4
“For comparison, data are presented for a well characterized TLR9 antagonist ODN 4084-F [47] (Figure 3).”
BackgroundMethodInnate immune responses to lysosomal nucleic acid stress
Miyake, K., Shibata, T., Sato, R., & Fukui, R. (2025) · The Journal of Biochemistry · doi:10.1093/jb/mvaf011 · Cited by 3
“Among these, TLR9 responds more strongly to bacterial double-stranded DNAs (dsDNAs) than self-derived DNAs based on sequences and methylation patterns (3) .”
Self-citationIsono, Y., Karasugi, C., Akisawa, T., Osawa, T., Ren, Q., Tatsuno, M., Ito, F., Inoué, T., Kawakami, J., Obika, S., et al. (2025) · Tetrahedron · doi:10.1016/j.tet.2025.134840 · Cited by 3
Structural immunotherapy: Harnessing chemical design to build powerful next-generation therapeutics
Teplensky, M. H., Bourgeois, J. N., Kudruk, S., Petrosko, S. H., & Mirkin, C. A. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2409553122 · Cited by 3
Ovine Toll-like Receptor 9 (TLR9) Gene Variation and Its Association with Flystrike Susceptibility
Liu, X., Zhou, H., Gong, H., Liu, W., Fang, Q., Luo, Y., Wang, J., Li, S., Hu, J., & Hickford, J. G. H. (2021) · Animals · doi:10.3390/ani11123549 · Cited by 3
Yu, H. L., Bai, L., Zhang, Y., Wang, Z., & Yu, Y. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5990 · Cited by 3
“This is in agreement with the results of previous studies (16,17).”
Hoshi, K., Yamazaki, T., Yoshikawa, C., Tsugawa, W., Ikebukuro, K., & Sode, K. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s166259 · Cited by 3
“2 Moreover, TLR9 forms a symmetrical TLR-CpG ODN complex with 2:2 stoichiometry, in which each dimer binds a CpG ODN.”
Synthetic Agonists of Toll-like Receptors and Therapeutic Applications
Agrawal, S., & Kandimalla, E. R. (2019) · Royal Society of Chemistry eBooks · doi:10.1039/9781788015714-00306 · Cited by 5
Tan, M., Takahashi, N., Fujii, S., Sakurai, K., Kusamori, K., Takahashi, Y., Takakura, Y., & Nishikawa, M. (2019) · ACS Applied Bio Materials · doi:10.1021/acsabm.9b00829 · Cited by 3
Codon usage signatures in Sabia and Chapare for host adaptation
Kumar, A. (2021) · Bioinformation · doi:10.6026/97320630017891 · Cited by 3
TELOMERE LENGTH, SEVERITY OF CORONAVIRUS INFECTION AND PREMATURE AGING (LITERATURE REVIEW)
Mironov, I. V., Гордиенко, А. В., D.Yu., S., Chumak, B. A., & Yakovlev, V. V. (2022) · Медико-фармацевтический журнал «Пульс» · doi:10.26787/nydha-2686-6838-2022-24-4-84-89 · Cited by 3
Structural and functional implications of leucine-rich repeats in toll-like receptor1 subfamily
Dey, D., Dhar, D., Das, S., Maulik, A., & Basu, S. (2022) · Journal of Biosciences · doi:10.1007/s12038-022-00300-8 · Cited by 3
“Quite a few crystal structures of TLR ectodomains complexed with their respective agonists, namely, TLR1-TLR2-tri-acylated lipopeptide, TLR2TLR6-di-acylated lipopeptide, TLR3-dsRNA, TLR4MD2-lipopolysaccharide, TLR5-flagellin, TLR8ssRNA, TLR9-CpG DNA, and TLR13-ssRNA, have been resolved (Jin et al. 2007; Liu et al. 200…”
BackgroundNucleic Acid Materials‐Mediated Innate Immune Activation for Cancer Immunotherapy
Xu, X., Hong, Y., Fan, H., & Guo, Z. (2024) · ChemMedChem · doi:10.1002/cmdc.202400111 · Cited by 4
TIR domains of TLR family-from the cell culture to the protein sample for structural studies
Лушпа, В. А., Goncharuk, M. V., Talyzina, I. A., Arseniev, A. S., Bocharov, E. V., Mineev, K. S., & Goncharuk, S. A. (2024) · PLoS ONE · doi:10.1371/journal.pone.0304997 · Cited by 4
Yan, H., Dong, B., Li, X., He, J., Yu, B., Mao, X., Yu, J., Luo, Y., Luo, J., Wu, A., et al. (2024) · Frontiers in Veterinary Science · doi:10.3389/fvets.2024.1467108 · Cited by 6
“On the other hand, M2 macrophages, also known as alternatively activated macrophages, focus on anti-inflammatory responses, tissue repair, and restoring immune balance after infections (35, 37–39).”
BackgroundEvolution of Small-Molecule Immunology Research—Changes Since CMC II
Dhar, T. G. M., & Dyckman, A. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12401-1 · Cited by 4
Small Molecule Modulators of Endo-lysosomal Toll-like Receptors
Talukdar, A., Mukherjee, A., & Ganguly, D. (2020) · Royal Society of Chemistry eBooks · doi:10.1039/9781788016544-00339 · Cited by 3
Innate and adaptive immunity in cancer
Doshi, A. S., & Asrani, K. H. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823397-9.00025-9 · Cited by 4
Developments in anticancer vaccination: budding new adjuvants
Santos‐Sierra, S. (2019) · Biological Chemistry · doi:10.1515/hsz-2019-0383 · Cited by 5
Carter, D., Duthie, M. S., & Reed, S. G. (2018) · Current topics in microbiology and immunology · doi:10.1007/82_2018_112 · Cited by 5
Metadata
- Authors
- Ohto, U., Shibata, T., Tanji, H., Ishida, H., Krayukhina, E., Uchiyama, S., Miyake, K., & Shimizu, T.
- Affiliations
- The University of Tokyo (JP)
- Japan Science and Technology Agency (JP)
- The University of Osaka (JP)
- Institute of Medical Science, The University of Tokyo (JP)
- Corresponding author
- Shimizu, Toshiyuki
- Venue
- Nature
- Published
- 2015-02-09
- Volume
- 520
- Issue
- 7549
- Pages
- 702-705
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2129961630
- Semantic Scholar
- 385253b727f67c70b401c7d39f56cdcb8ddf5dc1
- Cited by
- 377
- References
- 34
- Citations by year
- 2026: 30 · 2025: 30 · 2024: 32 · 2023: 36 · 2022: 33 · 2021: 31 · 2020: 33 · 2019: 28 · 2018: 36 · 2017: 30 · 2016: 43 · 2015: 15
- FWCI
- 20.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Japan Society for the Promotion of Science (25121722, 25253032, 25291010)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA and Nucleic Acid Chemistry
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- TLR9, CpG DNA, innate immunity, TLR9 activation, crystal structure, ligand binding, leucine-rich repeats, stem-loop structure, intramolecular base pairing
- MeSH terms
- Animals, Base Sequence, DNA, Humans, Ligands, Models, Molecular, Nucleic Acid Conformation, Structure-Activity Relationship, Protein Structure, Tertiary, Crystallography, X-Ray, CpG Islands, Toll-Like Receptor 9
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.